[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334642-105":59,"doc-detail-334642-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","epidermal-growth-factor-receptor-inhibition-potentiates-chemotherapeutics-mediated-sensitization-of-metastatic-breast-cancer-stem-cells","Epidermal growth factor receptor inhibition potentiates chemotherapeutics-mediated sensitization of metastatic breast cancer stem cells","","Background: Metastasis drives poor prognosis and relapse in triple-negative breast cancer (TNBC), largely through breast cancer stem cells (CSCs). Higher epidermal growth factor receptor (EGFR) expression in these CSCs supports EGFR as a therapeutic molecular target, motivating effective EGFR inhibitors. Aim: Develop EGFR inhibitors that potentiate chemotherapeutic mitigation of breast cancer tumorigenesis. Methods and Results: Small-molecule EGFR inhibitors were found via molecular docking, tested for cytotoxicity, then evaluated for effects on doxorubicin-induced migration, in-vitro tumorigenesis, and apoptosis-related gene and protein markers in TNBC cells.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/epidermal-growth-factor-receptor-inhibition-potentiates-chemotherapeutics-mediated-sensitization-of-metastatic-breast-cancer-stem-cells/334642/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/epidermal-growth-factor-receptor-inhibition-potentiates-chemotherapeutics-mediated-sensitization-of-metastatic-breast-cancer-stem-cells/334642.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What problem does the study address in TNBC patients?","Question",{"text":113,"@type":114},"The study targets metastasis-driven poor prognosis and relapse in triple-negative breast cancer, which is associated with breast cancer stem cells.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What is the main goal of the research?",{"text":118,"@type":114},"The research aims to design efficacious EGFR inhibitors that can potentiate chemotherapeutic-mediated mitigation of breast cancer tumorigenesis.",{"name":120,"@type":111,"acceptedAnswer":121},"How were the EGFR inhibitors identified and evaluated?",{"text":122,"@type":114},"Small-molecule EGFR inhibitors were identified using molecular docking, screened in vitro for cytotoxicity, and then tested for effects on doxorubicin-induced migration, in-vitro tumorigenesis, and apoptosis-related gene and protein markers.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},334642,1790012949,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":4},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","DOI: 10.1002/cnr2.2049  \nO R IG INA L ARTI CLE  \nEpidermal growth factor receptor inhibition potentiates chemotherapeutics-mediated sensitization of metastatic breast cancer stem cells  \nTrisha Kar 1,2 | Prachi Dugam 1 | Surbhi Shivhare 1,2 | Swathi R. Shetty 1,2 | Subholakshmi Choudhury 1,2 | Debanjan Sen 3 | Barnali Deb 4 |  \nSwapan Majumdar 4 | Sudhan Debnath 5 | Amitava Das 1,2   \n1Department of Applied Biology, Council of Scientific and Industrial Research-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad, Telangana, India 2Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India  \n3Department of Pharmaceutical Chemistry, BCDA College of Pharmacy and Technology, Kolkata, West Bengal, India 4Department of Chemistry, Tripura University, Agartala, Tripura, India  \n5Department of Chemistry, Netaji Subhash Mahavidyalaya, Udaipur, Tripura, India  \nCorrespondence  \nAmitava Das, Council of Scientific and Industrial Research-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad, Telangana, India.  \nEmail: [amitavadas@iict.res.in](amitavadas@iict.res.in); amitavadas. iict@ [gov.in](gov.in)  \nAbstract  \nBackground: Metastasis has been a cause of the poor prognosis and cancer relapse of triple-negative breast cancer (TNBC) patients. The metastatic nature of TNBC is contributed by the breast cancer stem cells (CSCs) which have been implicated in tumorigenesis. Higher expression of epidermal growth factor receptor (EGFR) in breast CSCs has been used as a molecular target for breast cancer therapeutics. Thus, it necessitates the design and generation of efficacious EGFR inhibitors to target the downstream signaling associated with the cellular proliferation and tumorigenesis of breast cancer.  \nAim: To generate efficacious EGFR inhibitors that can potentiate the chemotherapeuticmediated mitigation of breast cancer tumorigenesis.  \nMethods and Results: We identified small molecule EGFR inhibitors using molecular docking studies. In-vitro screening of the compounds was undertaken to identify the cytotoxicity profile of the small-molecule EGFR inhibitors followed by evaluation of the non-cytotoxic compounds in modulating the doxorubicin-induced migration, invitro tumorigenesis potential, and their effect on the pro-apoptotic genes' and protein markers' expression in TNBC cells. Compound 1e potentiated the doxorubicinmediated inhibitory effect on proliferation, migration, in-vitro tumorigenesis capacity, and induction of apoptosis in MDA-MB-231 cells, and in the sorted CD24+-breast cancer cells and CD24 􀀁 /CD44+-breast CSC populations. Orthotopic xenotransplantation of the breast CSCs-induced tumors in C57BL/6J mice was significantly  \n\n| Trisha Kar and Prachi Dugam contributed equally to this work. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.\u003Cbr>© 2024 The Authors. Cancer Reports published by Wiley Periodicals LLC. |\n\nCancer Reports. 2024;7:e2049 .  \n[https://doi.org/10.1002/cnr2.2049](https://doi.org/10.1002/cnr2.2049)  \n[wileyonlinelibrary.com/journal/cnr2](wileyonlinelibrary.com/journal/cnr2)  \n1 of 17  \ninhibited by the low dose of Doxorubicin in the presence of compound 1e as depicted by molecular and immunohistochemical analysis.  \nConclusion: Thus, the study suggests that EGFR inhibition-mediated sensitization of the aggressive and metastatic breast CSCs in TNBCs toward chemotherapeutics may reduce the relapse of the disease.  \nKEYWOR DS  \nbreast cancer, chemosensitization, EGFR, EGFR inhibitors, orthotopic xenotransplantation  \n1 | INTRODUCTION  \nBreast cancer, among all types of cancers, is the second major cause of mortality in women. It represents 18 .46% of all cancers leading to high mortality among women.1 Unlike other subtypes of breast cancer, triple-negative breast cancer cells (TNBCs) lack the expression of hormonal rec","cbCaij4haiF09MqA","https://ap.wps.com/l/cbCaij4haiF09MqA","pdf",17718754,17,"English","# Introduction\n## Breast cancer and TNBC background\n## Cancer stem cells and metastasis\n## CD24/CD44 markers and EGFR as a biomarker\n## Prior work linking EGFR inhibition to chemosensitization","[{\"question\":\"What problem does the study address in TNBC patients?\",\"answer\":\"The study targets metastasis-driven poor prognosis and relapse in triple-negative breast cancer, which is associated with breast cancer stem cells.\"},{\"question\":\"What is the main goal of the research?\",\"answer\":\"The research aims to design efficacious EGFR inhibitors that can potentiate chemotherapeutic-mediated mitigation of breast cancer tumorigenesis.\"},{\"question\":\"How were the EGFR inhibitors identified and evaluated?\",\"answer\":\"Small-molecule EGFR inhibitors were identified using molecular docking, screened in vitro for cytotoxicity, and then tested for effects on doxorubicin-induced migration, in-vitro tumorigenesis, and apoptosis-related gene and protein markers.\"}]","Epidermal growth factor receptor inhibition potentiates chemotherapeutics-mediated sensitization of metastatic breast cancer stem cells | PDF",1790007627,43]